Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 26, Issue 8, 2011, Pages 2630-2634

  Chazot, Charles ^a   Vo Van, Cyril ^a   Zaoui, Eric ^b   Vanel, Thierry ^a   Hurot, Jean Marc ^a   Lorriaux, Christie ^a   Mayor, Brice ^a   Deleaval, Patrick ^a   Jean, Guillaume ^a  

^a NephroCare ^*  (France)

^b Unilab   (France)

Author keywords

brain natriuretic peptide; cardiac disease; haemodialysis; incident patients; systolic blood pressure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGE; AGED; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART DISEASE; HEMODIALYSIS PATIENT; HUMAN; HYPERVOLEMIA; IMMUNOASSAY; INCIDENCE; MALE; MOLECULAR EVOLUTION; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REFERENCE VALUE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE;

AGED; BIOLOGICAL MARKERS; FEMALE; FLUID THERAPY; FOLLOW-UP STUDIES; FRANCE; GLOMERULAR FILTRATION RATE; HEART DISEASES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 79961097993     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq804     Document Type: Article

References (21)

1. Twardowski SJ. Sodium, hypertension, and an explanation of the "lag phenomenon" in hemodialysis patients. Hemodial Int 2008;12:412-425
2. Chazot C, Charra B, Vo Van C et al. The Janus-faced aspect of 'dry weight'. Nephrol Dial Transplant 1999;14:121-124
3. van de Pol AC, Frenken LA, Moret K et al. An evaluation of blood volume changes during ultrafiltration pulses and natriuretic peptides in the assessment of dry weight in hemodialysis patients. Hemodial Int 2007;11:51-61 (Pubitemid 46128681)
4. Fagugli RM, Palumbo B, Ricciardi D et al. Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron Clin Pract 2003;95:c60-c66
5. Zoccali C, Mallamaci F, Benedetto F et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001;12:1508-1515 (Pubitemid 32666334)
6. Mallamaci F, Tripepi G, Cutrupi S et al. Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int 2005;67:2330-2337 (Pubitemid 41623394)
7. Chazot C, Jean G, Vo-Van C et al. The plasma level of brain natriuretic peptide is increased in malnourished hemodialysis patients. Blood Purif 2009;28:187-192
8. Tagore R, Ling LH, Yang H et al. Natriuretic peptides in chronic kidney disease. Clin J Am Soc Nephrol 2008;3:1644-1651
9. Cataliotti A, Malatino LS, Jougasaki M et al. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc 2001;76:1111-1119 (Pubitemid 33032388)
10. Mark PB, Stewart GA, Gansevoort RT et al. Diagnostic potential of circulating natriuretic peptides in chronic kidney disease. Nephrol Dial Transplant 2006;21:402-410 (Pubitemid 43159995)
11. Essig M, Escoubet B, de Zuttere D et al. Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease. Nephrol Dial Transplant 2008;23:239-248 (Pubitemid 351767367)
12. Suresh M, Farrington K. Natriuretic peptides and the dialysis patient. Semin Dial 2005;18:409-419 (Pubitemid 41545876)
13. Wahl HG, Graf S, Renz H et al. Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis. Clin Chem 2004;50:1071-1074 (Pubitemid 38725801)
14. Charra B, Laurent G, Chazot C et al. Clinical assessment of dry weight. Nephrol Dial Transplant 1996;11:16-19 (Pubitemid 26182537)
15. Agarwal R, Alborzi P, Satyan S et al. Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 2009;53:500-507
16. Lee SW, Song JH, Kim GA et al. Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Am J Kidney Dis 2003;41:1257-1266 (Pubitemid 36637982)
17. Toz H, Ozkahya M, Ozerkan F et al. Improvement in "uremic" cardiomyopathy by persistent ultrafiltration. Hemodial Int 2007;11:46-50 (Pubitemid 46128680)
18. Odar-Cederlof I, Bjellerup P, Williams A et al. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction. Hemodial Int 2006;10:394-398 (Pubitemid 44489926)
19. Wabel P, Moissl U, Chamney P et al. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 2008;23:2965-2971
20. Wizemann V, Wabel P, Chamney P et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 2009;24:1574-1579
21. Iwashima Y, Horio T, Takami Y et al. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kidney Dis 2002;40:974-982 (Pubitemid 35265477)